(Q47903275)

English

Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy

scientific article published in April 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/19407842

Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/19407842

1 reference

based on heuristic

inferred from title

neovascular glaucoma

1 reference

based on heuristic

inferred from title

author name string

K Ghasemi Falavarjani

1

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/19407842

M Modarres

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/19407842

H Nazari

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/19407842

publication date

1 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/19407842

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/19407842

24

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/19407842

4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/19407842

717-719

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/19407842

https://scigraph.springernature.com/pub.10.1038/eye.2009.94

0 references

Vascular endothelial growth factor: basic science and clinical progress

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.94

21 January 2018

Vitreous levels of unbound bevacizumab and unbound vascular endothelial growth factor in two patients

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.94

21 January 2018

Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.94

21 January 2018

Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.94

21 January 2018

Evaluation of anterior chamber inflammatory activity in eyes treated with intravitreal bevacizumab

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.94

21 January 2018

Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.94

21 January 2018

Intravitreal injection of 2.5 mg versus 1.25 mg bevacizumab (Avastin) for treatment of CNV associated with AMD.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.94

21 January 2018

Testing intravitreal toxicity of bevacizumab (Avastin).

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.94

21 January 2018

Intravitreal bevacizumab for choroidal neovascularization caused by AMD (IBeNA Study): results of a phase 1 dose-escalation study

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.94

21 January 2018

Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.94

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracameral bevacizumab for iris rubeosis

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.94

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/EYE.2009.94

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/19407842

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/19407842

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47903275&oldid=2175467170"